✦ LIBER ✦

Hepatitis B surface antigen seroconversion is associated with favourable long-term clinical outcomes during lamivudine treatment in HBeAg-negative chronic hepatitis B patients

✍ Scribed by R. Idilman; K. Cinar; G. Seven; Y. Bozkus; A. Elhan; M. Bozdayi; C. Yurdaydin; K. Bahar

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Long-term outcome after spontaneous HBeA

✍ Yao-Shih Hsu; Rong-Nan Chien; Chau-Ting Yeh; I-Shyan Sheen; Hung-Yi Chiou; Chia- 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 105 KB

Efficacy of Long-Term Lamivudine Monothe

✍ Stephanos J Hadziyannis; George V Papatheodoridis; Evangelini Dimou; Andreas Lar 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 166 KB

Lamivudine monotherapy in HBeAg-negative

✍ S. MANOLAKOPOULOS; S. BETHANIS; J. ELEFSINIOTIS; S. KARATAPANIS; C. TRIANTOS; G. 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 134 KB

Long-Term Outcome after Hepatitis B Surf

✍ Yasuji Arase; Kenji Ikeda; Fumitaka Suzuki; Yoshiyuki Suzuki; Satoshi Saitoh; Ma 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 267 KB

362 SERUM HEPATITIS B SURFACE ANTIGEN LE

✍ P.-N. Cheng; H.-W. Tsai; T.-T. Chang 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 88 KB

Focus: Long-term treatment with lamivudi

✍ Daniel Shouval 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 162 KB